See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
11:01am, Thursday, May 01, 2025
Agios Pharmaceuticals Reports Q1 2025 Financials: Revenue Up but Losses Widen Amid Costs
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) has released its quarterly financial results for Q1 2025, highlighting both challenges and advancements in its development pipeline. Positive Aspects: Revenue Growth: Product revenue increased to $8.7 million for Q1 2025, up from $8.2 million in Q1 2024...
Read More